APA

Michielsens C. A. J., Boers N., den Broeder N., Wenink M. H., van der Maas A., Mahler E. A. M., Mulder M. L. M., van der Heijde D., van den Hoogen F. H. J., Verhoef L. M. & den Broeder A. A. (20201118). Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. : Trials.

Chicago

Michielsens Celia A J, Boers Nadine, den Broeder Nathan, Wenink Mark H, van der Maas Aatke, Mahler Elien A M, Mulder Michelle L M, van der Heijde Désirée, van den Hoogen Frank H J, Verhoef Lise M and den Broeder Alfons A. 20201118. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. : Trials.

Harvard

Michielsens C. A. J., Boers N., den Broeder N., Wenink M. H., van der Maas A., Mahler E. A. M., Mulder M. L. M., van der Heijde D., van den Hoogen F. H. J., Verhoef L. M. and den Broeder A. A. (20201118). Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. : Trials.

MLA

Michielsens Celia A J, Boers Nadine, den Broeder Nathan, Wenink Mark H, van der Maas Aatke, Mahler Elien A M, Mulder Michelle L M, van der Heijde Désirée, van den Hoogen Frank H J, Verhoef Lise M and den Broeder Alfons A. Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial. : Trials. 20201118.